Detection of Clinically Relevant Pain Relief in Cats with Degenerative Joint Disease Associated Pain

Background

Detection of clinically relevant pain relief in cats with degenerative joint disease (DJD) is complicated by a lack of validated outcome measures and a placebo effect.

Hypothesis/Objectives

To evaluate a novel approach for detection of pain relief in cats with DJD.

Animals

Fifty‐eight client‐owned cats.

Methods

Prospective, double‐masked, placebo‐controlled, stratified, randomized, clinical study. Enrolled cats were 6–21 years of age, with owner‐observed mobility impairment, evidence of pain in at least 2 joints during orthopedic examination, and overlapping radiographic evidence of DJD, and underwent a 2‐week baseline period, 3‐week treatment period with placebo or meloxicam, and 3‐week masked washout period. Outcome measures were evaluated at days 0, 15, 36, and 57.

Results

Both groups significantly improved after the treatment period (day 36) on client‐specific outcome measures (CSOM) and feline musculoskeletal pain index (FMPI) (P < .0001 for both); there was no difference between the groups on CSOM or FMPI score improvement. After the masked washout period, more cats that received meloxicam during the treatment period had a clinically relevant decrease in CSOM score (P = .048) and FMPI score (P = .021) than cats that received placebo.

Conclusions and Clinical Importance

Using both a client‐specific and a general clinical metrology instrument, owners of cats with DJD were able to detect evident recurrence of clinical signs after withdrawal of active medication than after withdrawal of placebo, and that this study design might be a novel and useful way to circumvent the placebo effect and detect the efficacy of pain‐relieving medications.     

致仔猪水肿病大肠杆菌减毒株的毒力测定及其在仔猪肠道内增殖的分析

在已构建致仔猪水肿病大肠杆菌S451521菌株的2个毒素敲除菌株（F1、F2）基础上,进一步测定了其毒力及在仔猪肠道内的繁殖能力。选择30日龄的ICR小鼠并随机分成4组,A、B、C试验组分别灌胃接种不同浓度的野生菌株S451521及其毒素敲除菌株F1、F2,D组以灭菌生理盐水作阴性对照;结果表明减毒菌株F1和F2毒力均比野生菌株弱,其中F1株减弱了60.73%、F2株减弱了84.38%。选择24日龄未经仔猪水肿病疫苗免疫过的仔猪共14头,并随机分为2组;第1组口服接种减毒菌株F2,第2组以灭菌生理盐水作阴性对照,定期采集仔猪粪样并进行细菌监测;结果显示,仔猪排出减毒菌株F2的数量随时间不断增多,在接种后28d可达到每克粪样含目的菌约70 000cfu。这说明减毒菌株F2能够在仔猪体内定植并大量繁殖。     

不同灌溉方式与寒地水稻病害发生和产量形成的关系

为探索适合黑龙江地区的水田灌溉方式,以空育131为试材,通过田间小区试验,研究了不同灌溉方式与寒地水稻主要病害发生和产量形成的关系。结果表明:病害发生种类与灌溉方式无显著相关性,但与病害发生程度有紧密联系。常规灌溉的水稻叶瘟、鞘腐病、褐变穗发病率和病情指数均最高。控水灌溉和节水灌溉病害发生较轻。产量方面,控水灌溉的产量最高,为10 049.03kg·hm-2,比常规灌溉增产6.81%,增产效果明显。     

桑树轮纹病病原菌的分离鉴定及其生物学特性研究

2012年6～8月,通过对桑树轮纹病病原菌分离、田间致病性测定、病原菌形态观察,将该病原菌鉴定为桑膝节霉,并对此病病原菌的生物学特性进行了研究。结果表明,不同培养基配方、温度、酸碱度、碳源、氮源、光照对桑树轮纹病病原菌菌丝的生长有一定影响,菌丝生长的最适宜培养基是理查培养基,最适温度是25℃,最适pH值是7.0,最适碳源为葡萄糖,最适氮源为蛋白胨,光照对菌丝生长无显著性差异,菌丝的致死温度和时间分别为85℃和10 min。对该病病原菌生物学特性研究为云南首次报道,对桑树轮纹病的防治具有一定的参考价值。     

根域限制条件下基质栽培对夏黑葡萄生长和果实品质的影响

[目的]研究根域限制条件下基质栽培与夏黑葡萄生长的关系,为休闲观光、庭院栽培葡萄提供理论依据.[方法]以夏黑葡萄为试材,以沙子和椰糠（体积比1∶4）为基质,以根域限制泥土栽培及露地泥土栽培为对照,分析根域限制条件下基质栽培对夏黑葡萄茎粗、产量、品质和病情指数的影响.[结果]根域限制基质栽培条件下,夏黑葡萄植株生长、产量、品质和抗病性等与根域限制泥土栽培差异不明显,其主干粗度、单果重、单穗重及产量均明显小于露地泥土栽培,而果实可溶性固形物含量、抗病能力均优于露地泥土栽培.[结论]根域限制基质栽培夏黑葡萄效果与泥土栽培相似,是适合观光农场、庭院绿化栽培推广应用的新方法.     

A型口蹄疫病毒VP1蛋白间接ELISA检测方法的建立

以原核表达经纯化复性制备的A型口蹄疫病毒(FMDV)VP1蛋白代替传统病毒抗原包被,建立快速、安全、有效的A型FMDV抗体ELISA检测方法。对前期制备的A型VP1蛋白进行Western-Blot检测,结果表明,VP1蛋白能够特异性识别A型FMDV阳性牛血清,可作为检测抗原建立检测A型FMDV抗体的方法。以最佳质量浓度1mg/L VP1蛋白为检测抗原,方阵滴定法确定最佳检测血清稀释度为1∶50[V(血清)∶V(封闭液)],最佳的酶标二抗稀释度为1∶2 000[V(酶标二抗)∶V(封闭液)],建立A型FMDV抗体ELISA检测方法。该方法的敏感性为94.32%,特异性为99.09%,批内与批间重复试验变异系数均小于8%。采用该方法检测201份临床血清,与液相阻断ELISA试剂盒的符合率达92.54%。研制的VP1-ELISA试剂盒特异、敏感、稳定、操作简便,可用来监控A型口蹄疫抗体水平。     

猪繁殖与呼吸综合征的抗病育种研究进展

猪繁殖与呼吸综合征(porcine reproductive and respiratory syndrome,PRRS)是近期危害养猪业最重要的疾病之一。培育抗病性品种是该病综合防治的一个有效方法。文章围绕该病抗病育种候选基因研究的主要进展进行综述,内容涉及病毒特异性受体基因、先天性免疫相关基因、抗原递呈信号通路相关基因、胞内miRNA等,并重点就今后PRRSV疾病耐受性和提高适应性免疫应答能力的研究进行展望。     

百色市番茄病虫害综合防控主要技术措施

本文作者从农业防治、生物防治、物理诱控、化学防治等方面详见地归纳总结了百色市番茄病虫害综合防控主要技术措施。